Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. Summary
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
06/11/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
72.1 70.05 66.2 66.7 68.5 Last
689553 1917036 1762766 2613522 2774351 Volume
-1.03% -2.84% -5.50% +0.76% +2.70% Change
Financials
Sales 2021 632 M 97,9 M 97,9 M
Net income 2021 30,1 M 4,66 M 4,66 M
Net cash position 2021 2 505 M 388 M 388 M
P/E ratio 2021 791x
Yield 2021 -
Sales 2022 1 175 M 182 M 182 M
Net income 2022 290 M 44,9 M 44,9 M
Net cash position 2022 2 353 M 365 M 365 M
P/E ratio 2022 85,5x
Yield 2022 -
Capitalization 25 111 M 3 891 M 3 892 M
EV / Sales 2021 35,8x
EV / Sales 2022 19,4x
Nbr of Employees 509
Free-Float 68,6%
More Financials
Company
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and... 
Read more
More about the company
Ratings of Venus Medtech (Hangzhou) Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about VENUS MEDTECH (HANGZHOU) INC.
05/06VENUS MEDTECH HANGZHOU  : Voluntary announcement latest investment project
PU
05/05VENUS MEDTECH HANGZHOU  : Invests in Medical Device Manufacturer
MT
04/20VENUS MEDTECH HANGZHOU  : Proxy form for use at the 2021 first class meeting of ..
PU
04/20VENUS MEDTECH HANGZHOU  : Proxy form for use at the 2021 first class meeting of ..
PU
04/20VENUS MEDTECH HANGZHOU  : Notice of 2021 first class meeting of holders of unlis..
PU
04/20VENUS MEDTECH HANGZHOU  : Notice of 2021 first class meeting of holders of h sha..
PU
04/06VENUS MEDTECH HANGZHOU  : Trims Loss in 2020 as Revenue Soars 18%
MT
01/21VENUS MEDTECH HANGZHOU  : Seeks $181 Million from Private Placement to Fund R&D;..
MT
01/21VENUS MEDTECH HANGZHOU  : CEP Device Completed First Clinical Application in Chi..
MT
2020VENUS MEDTECH HANGZHOU  : Wins Regulatory Nod to Sell Prosthetic Aortic Valve Pr..
MT
2020VENUS MEDTECH HANGZHOU  : Articles of association
PU
2020VENUS MEDTECH HANGZHOU  : Next Day Disclosure Return
PU
2020VENUS MEDTECH HANGZHOU  : Completion of placing of new h shares under general ma..
PU
2020VENUS MEDTECH HANGZHOU  : Taps into Surgical Heart Valve Market by Cooperating w..
PR
2020VENUS MEDTECH HANGZHOU  : Inside information announcement approval by csrc of th..
PU
More news
News in other languages on VENUS MEDTECH (HANGZHOU) INC.

- No features available -

More news
Chart VENUS MEDTECH (HANGZHOU) INC.
Duration : Period :
Venus Medtech (Hangzhou) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VENUS MEDTECH (HANGZHOU) INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 71,83 CNY
Last Close Price 56,94 CNY
Spread / Highest target 44,8%
Spread / Average Target 26,2%
Spread / Lowest Target 4,07%
EPS Revisions
Managers and Directors
NameTitle
Zhen Jun Zi Executive Director & General Manager
Haiyue Ma Chief Financial Officer & Joint Secretary
Min Zeng Chairman
Yan Xiao Chairman-Supervisory Board
Hou-Sen Lim Executive Director, COO & Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
VENUS MEDTECH (HANGZHOU) INC.-13.35%3 891
STRYKER CORPORATION4.03%96 037
SMITH & NEPHEW PLC1.23%18 515
INSPIRE MEDICAL SYSTEMS, INC.-1.15%5 060
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.46.50%4 105
GLAUKOS CORPORATION8.82%3 788